OncoImmunology (Jan 2021)

T cells drive negative feedback mechanisms in cancer associated fibroblasts, promoting expression of co-inhibitory ligands, CD73 and IL-27 in non-small cell lung cancer

  • Richard A O’Connor,
  • Vishwani Chauhan,
  • Layla Mathieson,
  • Helen Titmarsh,
  • Lilian Koppensteiner,
  • Irene Young,
  • Giulia Tagliavini,
  • David A Dorward,
  • Sandrine Prost,
  • Kevin Dhaliwal,
  • William A Wallace,
  • Ahsan R Akram

DOI
https://doi.org/10.1080/2162402X.2021.1940675
Journal volume & issue
Vol. 10, no. 1

Abstract

Read online

The success of immune checkpoint therapy shows tumor-reactive T cells can eliminate cancer cells but are restrained by immunosuppression within the tumor micro-environment (TME). Cancer associated fibroblasts (CAFs) are the dominant stromal cell in the TME and co-localize with T cells in non-small cell lung cancer. We demonstrate the bidirectional nature of CAF/T cell interactions; T cells promote expression of co-inhibitory ligands, MHC molecules and CD73 on CAFs, increasing their production of IL-6 and eliciting production of IL-27. In turn CAFs upregulate co-inhibitory receptors on T cells including the ectonucleotidase CD39 promoting development of an exhausted but highly cytotoxic phenotype. Our results highlight the bidirectional interaction between T cells and CAFs in promoting components of the immunosuppressive CD39, CD73 adenosine pathway and demonstrate IL-27 production can be induced in CAF by activated T cells.

Keywords